Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2009 1
2010 4
2012 3
2013 2
2014 4
2015 4
2016 2
2017 2
2018 6
2019 3
2020 17
2021 11
Text availability
Article attribute
Article type
Publication date

Search Results

53 results
Results by year
Filters applied: . Clear all
Page 1
A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice.
Freyn AW, Ramos da Silva J, Rosado VC, Bliss CM, Pine M, Mui BL, Tam YK, Madden TD, de Souza Ferreira LC, Weissman D, Krammer F, Coughlan L, Palese P, Pardi N, Nachbagauer R. Freyn AW, et al. Among authors: coughlan l. Mol Ther. 2020 Jul 8;28(7):1569-1584. doi: 10.1016/j.ymthe.2020.04.018. Epub 2020 Apr 19. Mol Ther. 2020. PMID: 32359470 Free PMC article.
Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection.
Rathnasinghe R, Strohmeier S, Amanat F, Gillespie VL, Krammer F, García-Sastre A, Coughlan L, Schotsaert M, Uccellini MB. Rathnasinghe R, et al. Among authors: coughlan l. Emerg Microbes Infect. 2020 Dec;9(1):2433-2445. doi: 10.1080/22221751.2020.1838955. Emerg Microbes Infect. 2020. PMID: 33073694 Free PMC article.
Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection.
Rathnasinghe R, Strohmeier S, Amanat F, Gillespie VL, Krammer F, García-Sastre A, Coughlan L, Schotsaert M, Uccellini M. Rathnasinghe R, et al. Among authors: coughlan l. bioRxiv. 2020 Jul 6:2020.07.06.190066. doi: 10.1101/2020.07.06.190066. Preprint. bioRxiv. 2020. PMID: 32676603 Free PMC article. Updated.
A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial.
Nachbagauer R, Feser J, Naficy A, Bernstein DI, Guptill J, Walter EB, Berlanda-Scorza F, Stadlbauer D, Wilson PC, Aydillo T, Behzadi MA, Bhavsar D, Bliss C, Capuano C, Carreño JM, Chromikova V, Claeys C, Coughlan L, Freyn AW, Gast C, Javier A, Jiang K, Mariottini C, McMahon M, McNeal M, Solórzano A, Strohmeier S, Sun W, Van der Wielen M, Innis BL, García-Sastre A, Palese P, Krammer F. Nachbagauer R, et al. Among authors: coughlan l. Nat Med. 2021 Jan;27(1):106-114. doi: 10.1038/s41591-020-1118-7. Epub 2020 Dec 7. Nat Med. 2021. PMID: 33288923 Clinical Trial.
Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Modified Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine.
Jangra S, De Vrieze J, Choi A, Rathnasinghe R, Laghlali G, Uvyn A, Van Herck S, Nuhn L, Deswarte K, Zhong Z, Sanders N, Lienenklaus S, David S, Strohmeier S, Amanat F, Krammer F, Hammad H, Lambrecht BN, Coughlan L, García-Sastre A, De Geest BG, Schotsaert M. Jangra S, et al. Among authors: coughlan l. bioRxiv. 2020 Oct 23:2020.10.23.344085. doi: 10.1101/2020.10.23.344085. Preprint. bioRxiv. 2020. PMID: 33106810 Free PMC article. Updated.
Snatching the Crown from SARS-CoV-2.
Coughlan L. Coughlan L. Cell Host Microbe. 2020 Sep 9;28(3):360-363. doi: 10.1016/j.chom.2020.08.007. Cell Host Microbe. 2020. PMID: 32910919 Free PMC article.
Biofilms in Food Processing Environments: Challenges and Opportunities.
Alvarez-Ordóñez A, Coughlan LM, Briandet R, Cotter PD. Alvarez-Ordóñez A, et al. Among authors: coughlan lm. Annu Rev Food Sci Technol. 2019 Mar 25;10:173-195. doi: 10.1146/annurev-food-032818-121805. Epub 2019 Jan 17. Annu Rev Food Sci Technol. 2019. PMID: 30653351 Review.
Adenoviral vectors as novel vaccines for influenza.
Coughlan L, Mullarkey C, Gilbert S. Coughlan L, et al. J Pharm Pharmacol. 2015 Mar;67(3):382-99. doi: 10.1111/jphp.12350. Epub 2015 Jan 5. J Pharm Pharmacol. 2015. PMID: 25560474 Review.
53 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page